Tacrolimus related diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome: an observational, retrospective, pharmacovigilance study

Information on the incidence and risk factors for diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar nonketotic syndrome (HHNS) caused by tacrolimus has rarely been reported. This study aims to assess the spectrum of DKA/HHNS associated with tacrolimus.